| Lawrence R Whicker, MD | |
|
7500 Hanover Pkwy, Suite 201, Greenbelt, MD 20770-2009 | |
| (301) 982-5008 | |
| (301) 441-8696 |
| Full Name | Lawrence R Whicker |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 40 Years |
| Location | 7500 Hanover Pkwy, Greenbelt, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891701694 | NPI | - | NPPES |
| 0500142 | Other | MD | UNITED HEALTHCARE |
| 16540007 | Other | DC | CAREFIRST BCBS |
| 528559 | Other | MD | AETNA USHC |
| 52544002 | Other | MD | CAREFIRST BCBS |
| 20164 | Other | MD | MAMSI |
| 912931600 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | D37979 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Neurological Medicine, P.a. | 2860438041 | 5 |
News Archive
The incidence of acute myocardial infarction in Italy sharply increased, particularly among young women, between the years 2001 and 2005, according to a comprehensive study funded by the Human Health Foundation, a nonprofit Italian charity for biomedical research and health education in Spoleto, Italy. The results were published in Aging Clinical Experimental Research.
SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that Harvard-affiliated Brigham and Women's Hospital in Boston has performed New England's first implant of the SynCardia temporary Total Artificial Heart.
LUNGevity Foundation, the nation's leading lung cancer nonprofit, applauds the Food and Drug Administration's approval of Bristol Myers Squibb's new immunotherapy drug Opdivo (nivolumab). Opdivo and other immunotherapy treatments add another critical new treatment option to fight lung cancer by harnessing the power of a patient's own immune system to fight cancerous cells.
Anti tumor necrosis factor therapy increases the risk of developing varicella zoster virus infections, including shingles and chicken pox, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Atlanta.
Using blood samples from an individual previously infected with Zika virus, scientists funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, have developed an antibody-based Zika virus therapeutic that protected monkeys from infection.
› Verified 2 days ago
| Entity Name | Neurological Medicine, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164594149 PECOS PAC ID: 2860438041 Enrollment ID: O20050629000080 |
News Archive
The incidence of acute myocardial infarction in Italy sharply increased, particularly among young women, between the years 2001 and 2005, according to a comprehensive study funded by the Human Health Foundation, a nonprofit Italian charity for biomedical research and health education in Spoleto, Italy. The results were published in Aging Clinical Experimental Research.
SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that Harvard-affiliated Brigham and Women's Hospital in Boston has performed New England's first implant of the SynCardia temporary Total Artificial Heart.
LUNGevity Foundation, the nation's leading lung cancer nonprofit, applauds the Food and Drug Administration's approval of Bristol Myers Squibb's new immunotherapy drug Opdivo (nivolumab). Opdivo and other immunotherapy treatments add another critical new treatment option to fight lung cancer by harnessing the power of a patient's own immune system to fight cancerous cells.
Anti tumor necrosis factor therapy increases the risk of developing varicella zoster virus infections, including shingles and chicken pox, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Atlanta.
Using blood samples from an individual previously infected with Zika virus, scientists funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, have developed an antibody-based Zika virus therapeutic that protected monkeys from infection.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lawrence R Whicker, MD 7500 Hanover Pkwy, Suite 201, Greenbelt, MD 20770-2009 Ph: (301) 982-5008 | Lawrence R Whicker, MD 7500 Hanover Pkwy, Suite 201, Greenbelt, MD 20770-2009 Ph: (301) 982-5008 |
News Archive
The incidence of acute myocardial infarction in Italy sharply increased, particularly among young women, between the years 2001 and 2005, according to a comprehensive study funded by the Human Health Foundation, a nonprofit Italian charity for biomedical research and health education in Spoleto, Italy. The results were published in Aging Clinical Experimental Research.
SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that Harvard-affiliated Brigham and Women's Hospital in Boston has performed New England's first implant of the SynCardia temporary Total Artificial Heart.
LUNGevity Foundation, the nation's leading lung cancer nonprofit, applauds the Food and Drug Administration's approval of Bristol Myers Squibb's new immunotherapy drug Opdivo (nivolumab). Opdivo and other immunotherapy treatments add another critical new treatment option to fight lung cancer by harnessing the power of a patient's own immune system to fight cancerous cells.
Anti tumor necrosis factor therapy increases the risk of developing varicella zoster virus infections, including shingles and chicken pox, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Atlanta.
Using blood samples from an individual previously infected with Zika virus, scientists funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, have developed an antibody-based Zika virus therapeutic that protected monkeys from infection.
› Verified 2 days ago
Dr. Dennis Richard Glick, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 7474 Greenway Center Dr, #730, Greenbelt, MD 20770 Phone: 301-982-3437 Fax: 301-982-9452 | |
William R Leahy, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 7500 Hanover Pkwy, Suite 201, Greenbelt, MD 20770 Phone: 301-982-7944 Fax: 301-441-8696 | |
Patricia Caraballo Osorio, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 7818 Cloister Pl, Greenbelt, MD 20770 Phone: 202-430-4366 | |
Dr. Maria C Hammill, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 7474 Greenway Center Dr, Suite 730, Greenbelt, MD 20770 Phone: 301-982-3437 Fax: 301-982-9452 | |
Jyoti Behl, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 7525 Greenway Center Dr, Suite 315, Greenbelt, MD 20770 Phone: 301-441-1026 Fax: 301-263-7948 | |
Syed W Asad, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 7500 Hanover Pkwy, Suite 201, Greenbelt, MD 20770 Phone: 301-982-7944 Fax: 301-441-8696 | |
Kenneth Michael Kudelko, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 7500 Hanover Pkwy, Suite 201, Greenbelt, MD 20770 Phone: 301-982-7944 Fax: 301-441-8696 |